Gp96 and its different expression in breast carcinomas
(31 — 35)
I. HODOROVA, S. RYBAROVA, P. SOLAR, J. VECANOVA, L. PROKOPCAKOVA, P. BOHUS, Z. SOLAROVA, Y. MELLOVA, K. SCHMIDTOVA
KLF6 IVS1 -27G/A polymorphism with susceptibility to gastric cancers
in Korean
(47 — 50)
Y. G. CHO, H. S. LEE, J. H. SONG, C. J. KIM, Y. K. PARK, S. W. NAM, N. J. YOO, J. Y. LEE, W. S. PARK
TRAIL receptors in the serum of patients with B-cell chronic
lymphocytic leukemia
(51 — 54)
E. JABLONSKA, B. KIERSNOWSKA-ROGOWSKA, M. ALEKSANDROWICZ-BUKIN, F. ROGOWSKI, J. SAWICKA-POWIERZA
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
(65 — 70)
U. COSKUN, S. BUYUKBERBER, E. YAMAN, A. UNER, O. ER, M. OZKAN, M. DIKILITAS, M. OGUZ, R. YILDIZ, D. YAMAC, B. OZTURK, A. O. KAYA, M. BENEKLI
Is obesity a preventive factor for lung cancer?
(71 — 73)
H. KOLLAROVA, L. MACHOVA, D. HORAKOVA, L. CIZEK, G. JANOUTOVA, V. JANOUT